Helus Pharma (HELP) announced the appointment of Dr. Freda Lewis-Hall, DFAPA, MFPM, to its Board of Directors. Dr. Lewis-Hall, former Pfizer (PFE) Chief Medical Officer, will also serve as Chair of the Company’s Scientific Advisory Committee. Dr. Lewis-Hall’s appointment to the Company’s board of directors is subject to approval of Cboe Canada.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HELP:
- Psychedelic: Exclusive talk with nonprofit organization MAPS
- Cybin (Helus Pharma) Names Veteran Pharma Executive Michael Cola as CEO to Drive CNS Growth
- Helus Pharma’s Short-Acting Depression Drug Shows Durable Benefit in Phase 2a Trial
- Helus Pharma announces Phase 2a study of SPL026 met primary endpoint
- Cybin (Helus Pharma) Posts Higher Assets, Equity and Losses in Q3 FY2026 SEC Filing